Form D · Other Health Care
Diabetes Reversal Group LLC
Dallas, TX · CIK 0002072089
Offering snapshot reported Mar 3, 2026 · SEC filing
- Reported sold
- $405K Offering amount: $550K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Nov 20, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2026 | Initial | $405,000 | No comparison | 6 | SEC filing |
| Jun 16, 2025 | Initial | $2,352,460 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-575275
Source: Form D, filed Mar 3, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Traci Hockings | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2200 Ross Ave. Suite 4400 E
Dallas, TX, 75201
Dallas, TX, 75201